Dimitri Lavillette

Title: The Innovations of Dimitri Lavillette

Introduction

Dimitri Lavillette is a notable inventor based in Lyons, France. He has made significant contributions to the field of virology and gene therapy, holding 2 patents that showcase his innovative work. His research focuses on the development of viral vectors and methods for detecting polypeptides, which have important implications in medical science.

Latest Patents

Lavillette's latest patents include "Lentiviral vectors pseudotyped with mutant BaEV glycoproteins" and "Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein." The first patent describes a pseudotyped viral vector particle designed for transferring biological material into cells. This vector particle features a chimeric envelope glycoprotein that combines elements from baboon endogenous retrovirus and murine leukemia virus. The second patent outlines a method for detecting the expression of specific polypeptides in cells, utilizing the fusogenic power of the polypeptide to establish detection through syncytia formation.

Career Highlights

Throughout his career, Lavillette has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and École Normale Supérieure de Lyon. His work at these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Lavillette has collaborated with notable colleagues, including Francois-Loic Cosset and Anais Girard-Gagnepain. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Dimitri Lavillette's contributions to the field of virology and gene therapy are significant, as evidenced by his patents and collaborations. His work continues to influence advancements in medical science and showcases the importance of innovation in addressing complex biological challenges.